US5096715A
(en)
*
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
US5013740A
(en)
*
|
1990-03-22 |
1991-05-07 |
Hillel Glover |
Method for treating emotional numbness and coma
|
US5086058A
(en)
*
|
1990-06-04 |
1992-02-04 |
Alko Ltd. |
Method for treating alcoholism with nalmefene
|
US5352680A
(en)
*
|
1992-07-15 |
1994-10-04 |
Regents Of The University Of Minnesota |
Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
|
US6096756A
(en)
*
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
USRE36547E
(en)
*
|
1992-09-21 |
2000-02-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
|
US5580876A
(en)
*
|
1992-09-21 |
1996-12-03 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
US5298622A
(en)
*
|
1993-05-12 |
1994-03-29 |
Regents Of The University Of Minnesota |
Spiroindane opiate analogs
|
US5457208A
(en)
|
1993-06-21 |
1995-10-10 |
Regents Of The University Of Minnesota |
Kappa opioid receptor antagonists
|
US5587381A
(en)
*
|
1995-03-27 |
1996-12-24 |
Sinclair; John D. |
Method for terminating methadone maintenance through extinction of the opiate-taking responses
|
US6001848A
(en)
*
|
1996-03-25 |
1999-12-14 |
The Regents Of The University Of California |
Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele
|
US5878750A
(en)
*
|
1996-11-14 |
1999-03-09 |
Clemens; Anton H. |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
CA2314893C
(en)
|
1997-12-22 |
2005-09-13 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist combinations
|
HUP0100310A3
(en)
|
1997-12-22 |
2002-11-28 |
Euro Celtique Sa |
A method of preventing abuse of opioid dosage forms
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
AU1807401A
(en)
*
|
1999-11-30 |
2001-06-12 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of breast cancer
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
EP1299104B1
(de)
|
2000-02-08 |
2009-05-13 |
Euro-Celtique S.A. |
Missbrauchssichere orale opioid-agonist zubereitungen
|
US20040024004A1
(en)
*
|
2001-05-04 |
2004-02-05 |
Sherman Barry M. |
Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
|
US6846831B2
(en)
|
2000-08-15 |
2005-01-25 |
Cpd, Llc |
Method of treating the syndrome of lipodystrophy
|
US6528520B2
(en)
|
2000-08-15 |
2003-03-04 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
US6262062B1
(en)
|
2000-08-15 |
2001-07-17 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
WO2003006980A1
(fr)
*
|
2001-07-13 |
2003-01-23 |
Arkray, Inc. |
Appareil d'analyse, corps a element de perçage integralement installe pour un dispositif de mesure de la temperature associe a l'appareil d'analyse, et appareil de prelevement de liquide organique
|
CA2454328C
(en)
|
2001-07-18 |
2008-03-18 |
Christopher D. Breder |
Pharmaceutical combinations of oxycodone and naloxone
|
CA2457361C
(en)
|
2001-08-06 |
2008-11-04 |
Christopher Breder |
Opioid agonist formulations with releasable and sequestered antagonist
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
US20030153590A1
(en)
*
|
2001-08-14 |
2003-08-14 |
Oy Contral Pharma Ltd |
Method of treating alcoholism or alcohol abuse
|
AU2002348135A1
(en)
*
|
2001-10-31 |
2003-05-12 |
Recovery Pharmaceuticals, Inc. |
Methods for the treatment of addiction
|
EP2425821B1
(de)
|
2002-04-05 |
2017-05-10 |
Euro-Celtique S.A. |
Pharmazeutische Zubereitung mit Oxycodon und Naloxon
|
HUE039377T2
(hu)
*
|
2002-05-31 |
2018-12-28 |
L Molteni & C Dei Fratelli Alitti Soc Di Esercizio S P A |
Beültethetõ polimer eszköz buprenorfin folytonos kibocsátására
|
EP2422773A3
(de)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren
|
WO2004078178A1
(en)
*
|
2003-03-03 |
2004-09-16 |
Markus Heilig |
Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use
|
MXPA05010450A
(es)
|
2003-03-31 |
2005-11-04 |
Titan Pharmaceuticals Inc |
Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
WO2004091593A2
(en)
*
|
2003-04-14 |
2004-10-28 |
Pain Therapeutics, Inc. |
Methods for the treatment of pain comprising opioid antagonists
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
EP1638536A2
(de)
*
|
2003-05-30 |
2006-03-29 |
Titan Pharmaceuticals, Inc. |
Implantierbare polymer-vorrichtung für die verzögerte freisetzung von nalmefen
|
US20060009478A1
(en)
*
|
2003-10-15 |
2006-01-12 |
Nadav Friedmann |
Methods for the treatment of back pain
|
US20050245461A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
US20050245541A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
US7919499B2
(en)
|
2004-04-22 |
2011-04-05 |
Alkermes, Inc. |
Naltrexone long acting formulations and methods of use
|
EP1604666A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
US7910599B2
(en)
|
2005-01-10 |
2011-03-22 |
John David Sinclair |
Method for treating eating disorders by selective extinction with transdermal naloxone
|
EP1702558A1
(de)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
US20070259939A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Accelerated Technologies |
Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness
|
KR20140079441A
(ko)
|
2006-06-19 |
2014-06-26 |
알파마 파머슈티컬스 엘엘씨 |
약제학적 조성물
|
EP1897543A1
(de)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine-Waffel zur Substitutionstherapie
|
SI2724722T1
(sl)
|
2006-10-20 |
2017-07-31 |
Neurendo Pharma, Llc |
Postopek za obnovitev učinka inkretina
|
FI20070705L
(fi)
|
2007-09-14 |
2009-06-02 |
Biohit Oyj |
Asetaldehydin sitominen suussa ja mahalaukussa
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
JP5886632B2
(ja)
|
2009-03-10 |
2016-03-16 |
ユーロ−セルティーク エス.エイ. |
オキシコドンおよびナロキソンを含む即時放出医薬組成物
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
KR20160034352A
(ko)
|
2013-07-23 |
2016-03-29 |
유로-셀티큐 에스.에이. |
장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
|
EP3139921A4
(de)
*
|
2014-05-06 |
2018-02-14 |
Purdue Pharma L.P. |
Benzomorphananaloga und verwendung davon
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
CN107405343A
(zh)
|
2014-11-07 |
2017-11-28 |
明尼苏达大学董事会 |
可用于治疗疾病的盐和组合物
|
KR102453781B1
(ko)
*
|
2016-06-24 |
2022-10-12 |
오피언트 파마슈티컬스, 인코퍼레이티드 |
알코올 사용 장애의 치료용 조성물, 장치 및 방법
|
AU2017360910B2
(en)
|
2016-11-18 |
2023-11-23 |
Aegis Therapeutics, Llc |
Compositions and methods for the treatment of opioid overdose
|